Beiersdorf and Rubedo team up to fight cellular aging

Beiersdorf and Rubedo Life Science have entered into a multi-year strategic partnership to develop breakthrough anti-aging solutions for the global facial care market. The German beauty giant also joined Rubedo as a strategic investor and participated in the recently closed Series A funding round through its Oscar & Paul Corporate Venture Capital Fund. Rubedo Life Science is a California-based biotechnology company with expertise in developing solutions targeting cellular aging.

The collaboration centers around the exploration of novel compounds derived from Rubedo’s extensive research program, specifically targeting cellular senescence.

Senescent cells, means to grow old, grow age Latin senescere accumulate with age and cause inflammation, which may contribute to age-related skin changes and pathologies. The collaboration will conduct in vivo human studies aimed at validating the effectiveness of selected substances in cosmetic skin care formulations.

As part of this collaboration, Beiersdorf will conduct in vitro and in silico studies and rigorously evaluate Rubedo's candidate compounds. The collaboration will conduct in vivo human studies aimed at validating the effectiveness of selected substances in cosmetic skin care formulations.

"Our mission is to define the future of skin care through breakthrough innovations," commented Vincent Warnery, CEO of Beiersdorf. “By partnering with Rubedo and combining our cutting-edge expertise, we aim to redefine the standard for anti-aging skincare. ”

Dr. Gitta Neufang, Senior Vice President of Global Research and Development at Beiersdorf AG, added: "We see great potential in this dynamic research area of cellular senescence to develop superior skin regeneration solutions. "

"This partnership has the potential to revolutionize the skin care landscape by combining Rubedo’s expertise in cellular aging with Beiersdorf’s expertise in skin care innovation, providing consumers with new solutions to treat cellular aging so skin looks healthy and youthful.” concludes Marco Quarta, CEO of Rubedo Life Sciences.